Importantly, high levels of serum MMPs are also reliable biomarkers indicative of metastatic progression and are associated with poor survival in gastric (MMP-14) (214) and breast (MMP-2 and MMP-9) (215) cancer patients. Here, MMP2 is linked to cancer.